Fujifilm Diosynth celebrates expansion in Denmark
Contract development and manufacturing organization Fujifilm Diosynth Biotechnologies held a ceremony on March 3 to celebrate the large-scale expansion of cell culture capacity at its production facility in Hillerød, Denmark. Read More
Amunix secures $117M to move lead candidate to clinical trials
Amunix Pharmaceuticals has raised $117 million in financing to fund the advancement of its lead T-cell engager candidate into the clinic. Read More
Biosero, Celltrio provide automated cell culture system
Biosero and Celltrio are integrating technologies to accelerate cell line culturing and harvesting processes, including cryogenic storage, into a modular end-to-end system. Read More
Nu-Tek to erect animal-free peptone facility
Nu-Tek Biosciences plans to build a new animal-free peptone facility in Austin, MN. Read More
Century Therapeutics closes $160M to advance preclinical cell therapies
Century Therapeutics has closed $160 million in financing to advance its preclinical pipeline of induced pluripotent stem cell-derived chimeric antigen receptor-iT and CAR-i natural killer cell products. Read More
Caribou nabs $115M to advance CRISPR-edited cell therapies
Caribou Biosciences has completed $115 million in financing to further develop its next-generation CRISPR technology platform and advance its pipeline of allogeneic immune cell therapies for oncology. Read More
AGC Biologics expands Milan manufacturing facilities
AGC Biologics said its plans to expand its cell and gene therapy center of excellence in Milan to increase and implement viral vector suspension capabilities. Read More
Scientists achieve milestone in animal-free production of biologics
For the first time, scientists have successfully produced sugar-based biologic molecules utilizing bacteria, without the need for animal products. The paper, published in Nature Communications on March 2, describes the production of a common designer polysaccharide, chondroitin sulfate. Read More
DNA Script to contribute to DARPA's mobile vaccine manufacturing platform
DNA Script has been selected by GE Research to join a collaboration to develop a rapid response, mobile medical manufacturing platform to enable on-demand production of nucleic acid-based vaccines and therapies. The project is part of a Defense Advanced Research Projects Agency (DARPA) program. Read More
Mesoblast gets $110M in financing from investor group
Mesoblast has entered into a subscription agreement to form a limited partnership with SurgCenter Development, a U.S.-based investor group, for a total of $110 million via the issue of 60 million shares. Read More
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter